General
Feon develops new-molecule-based liquid electrolytes for lithium-ion and lithium-metal batteries.
Developer of a battery technology designed to offer energy-dense and cost-efficient next-generation new electrolyte molecules. The company's technology uses liquid electrolytes and battery technology to unlock higher energy density at lower costs, it is positioned as a pharmaceutical company in the battery field, creating new drug molecules to treat diseases of next-generation batteries, enabling clients with affordable batteries for their electric vehicles and electric aircraft.